Khiron Life Sciences, a vertically intergrated Colombian cannabis company, has signed a deal to sell its CBD skin-care products in the Hong Kong region later this year.

Khiron signed the distribution agreement for its Kuida CBD skin-care line with DNO Group, an Asia-Pacific distributor with a network of more than 50,000 retail and online channels in the region.

Seven Kuida products will be distributed on the Hong Kong market, with first orders anticipated in the fourth quarter of this year, the company said in a statement released Monday. Distribution is conditional on the approval of Canada’s TSX Venture Exchange.


Colombia’s Khiron inks Hong Kong distribution deal for CBD skin-care line